- $435.43m
- $151.78m
- $740.84m
- 72
- 78
- 70
- 86
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 999 | 1,255 | 1,168 | 932 | 741 |
Cost of Revenue | |||||
Gross Profit | 294 | 372 | 366 | 251 | 249 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 973 | 1,186 | 1,101 | 1,015 | 768 |
Operating Profit | 26.2 | 69.3 | 66.6 | -82.9 | -27.3 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 29.6 | 70.8 | 65.5 | -82 | -19.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | 25.8 | 58.3 | 49.4 | -69 | -105 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 25.8 | 58.3 | 49.4 | -69 | -105 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 25.8 | 58.3 | 49.4 | -69 | -105 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.807 | 2.07 | 1.71 | -1.32 | -3.42 |